Showing 2301-2310 of 2494 results for "".
- Sifi Launches Well Fusion Presbyopia Correcting Systemhttps://modernod.com/news/sifi-launches-well-fusion-presbyopia-correcting-system/2478688/SIFI announces the launch of the Well Fusion system and the Mini Well Proxa IOL, offering a novel solution that provides cataract patients the option to treat presbyopia with spectacle-free uninterrupted high-quality vision at all distances and in all lighting conditions. SIFI has develope
- Influx of New Contact Lens Patients Calls for Simplified Wear-and-Care Educationhttps://modernod.com/news/influx-of-new-contact-lens-patients-calls-for-simplified-wear-and-care-education/2478671/Within days of mask guidelines being implemented earlier this year, the reports of fogging started streaming in from glasses and sunglasses wearers. Social feeds were soon packed with photos of the annoying condensation and news reports began offering tips on how to avoid condensation. In 2020, t
- Vaccine Rollout On Track, Expect 300M Doses Through March: Fedshttps://modernod.com/news/vaccine-rollout-on-track-expect-300m-doses-through-march-feds/2478672/If the initial success of the Pfizer-BioNTech rollout continues, and emergency use authorization (EAU) is granted to Moderna and Johnson & Johnson vaccines in development, Operation Warp Speed officials expect to have 300 million doses of COVID-19 vaccines to distribute across the United Stat
- Katena Products Announces Steve Blazejewski as New CEOhttps://modernod.com/news/katena-products-announces-steve-blazejewski-as-new-ceo/2478633/Katena Products announced that Steve Blazejewski has joined as Chief Executive Officer. As a seasoned executive, Mr. Blazejewski brings impressive leadership experience and medical device knowledge to Katena. He has previously served as President of Medical Solutions at Cardinal Health and
- Your Patient Plans to Travel Despite COVID-19 Risk? Here’s the Latest CDC Guidance to Sharehttps://modernod.com/news/your-patient-plans-to-travel-despite-covid-19-risk-heres-the-latest-cdc-guidance-to-share/2478627/Make no mistake: Federal officials recommend the American public stay home over the upcoming holidays in order to stem the spread of the COVID-19 pandemic. Cases of COVID-19 are surging across the country and flooding—in some cases, overwhelming—hospitals, pushing many to postpone elective
- Topcon Announces the US Launch of RDx Telehealth Software Platformhttps://modernod.com/news/topcon-announces-the-us-launch-of-rdx-telehealth-software-platform/2478617/Topcon Healthcare announced that it has launched its new Topcon RDx ocular telehealth software platform in the US market. Topcon RDx is an eye health exam platform that allows practitioners to connect to their office remotely and conduct comprehensive eye exams in real-time from virtual
- Alcon Canada to Launch a Professional Line of Systane Ultra Hydration Lubricant Eye Drops Preservative Freehttps://modernod.com/news/alcon-canada-to-launch-a-professional-line-of-systane-ultra-hydration-lubricant-eye-drops-preservative-free/2478607/Alcon announced the Canadian launch of the newest addition to its portfolio of dry eye products—a professional line of Systane Ultra Hydration Lubricant Eye Drops Preservative Free. These new eye drops contain both hyaluronic acid (HA) and HP-Guar, a combination of ingredients shown to offer long
- JetBlue, Virgin Atlantic Set to Roll Out COVID-19 ‘Health Pass’ App in Decemberhttps://modernod.com/news/jetblue-virgin-atlantic-set-to-roll-out-covid-19-health-pass-app-in-december/2478593/Following a successful test with United Airlines in October, four more major airlines plan to start offering passengers a digital health pass to certify they are COVID-19-free, according to a FierceHealthcare
- Stoke Therapeutics Nominates Next Preclinical Target in Genetic Eye Diseasehttps://modernod.com/news/stoke-therapeutics-nominates-next-preclinical-target-in-genetic-eye-disease/2478539/Stoke Therapeutics announced the nomination of OPA1 as its second preclinical candidate. “Based on new preclinical data, we are announcing today the expansion of our pipeline with the nomination of OPA1 as our next preclinical target,” Edward M. Kaye, MD, Chief Executive Offi
- I-MED Pharma Launches Tearcheck Dry Eye Analysis in Canadahttps://modernod.com/news/i-med-pharma-launches-tearcheck-dry-eye-analysis-in-canada/2478522/I-MED Pharma announced the Canadian launch of tearcheck, a diagnostic and analyzing tool that performs 9 exams in under 10 minutes. The tearcheck was designed and developed by the French manufacturer E-Swin and offers the newest technological advancements to simplify dry eye d